This is the first in a series of thematic notes from Ardabelle Capital covering market dynamics, competitive trends, and regulatory developments in the sectors we invest in.
Europe's industrial transition will not be won through a patchwork of isolated innovations or a collection of disconnected assets. It will be won by coherently rebuilding entire value chains — making them more resilient, more resource-efficient, and more sovereign.
At the intersection of onshoring, decarbonisation and the push for greater European autonomy, the real opportunity lies not in optimising the margins of what already exists, but in recomposing the systems that underpin production altogether.
This is what Ardabelle was built to do. We act as a conductor of ecosystemic change across value chains — identifying fragility points, securing critical assets, structuring upstream and downstream alliances, and orchestrating scale-up over the medium term. We are not passive shareholders; we build industrial roadmaps and develop with management teams a shared strategic narrative for the business.
This first note focuses on biostimulants, following our initial investment in Plymag — examining the pressure on conventional agriculture, the scalability of biostimulants as a response, and growing demand from major food players pursuing their Scope 3 targets.
Do not hesitate to reach out if you have any questions.
For Ardabelle Capital,
Eric Hazan and Noémie Flammarion
Biostimulants Overview — Ardabelle Capital (February 2026)